{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode'])) @else
@endif

A disease and management insight survey among healthcare practitioners on dermatophytosis in India

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What percentage of your patients visit for dermatophytosis condition? *
  2. What are the primary presenting complaints in dermatophytosis patients? *
  3. Of total tinea patients you see in your clinic, what is the % breakup of tinea on the basis of site of involvement? *
  4. Tinea capitis
    %
    Tinea faciei
    %
    Tinea barbae
    %
    Tinea corporis
    %
    Tinea cruris
    %
    Tinea pedis
    %
    Tinea manuum
    %
    Onychomycosis
    %
  5. Of total tinea patients you see in your clinic, what % is male population? *
  6. What percentage of your patients with dermatophytosis have comorbid conditions like hypertension, diabetes mellitus and obesity? *
  7. How many patients give history of applying OTC steroid cream? *
  8. Initial diagnosis of fungal infection is based on: (Multiple options can be selected) *
  9. In which particular scenario do you recommend fungal culture in dermatophytosis patients? *
  10. How do you treat a patient with fungal infection? (Multiple options can be selected) *
  11. What % of your dermatophytosis patients are treatment naïve and how do you treat them? *
  12. What % of your patients do you manage by only topical formulations? *
  13. When do you prefer topical formulation of anti-fungal? *
  14. In which all conditions do you use only topical formulations in your patients? *
  15. What is the 1st, 2nd and 3rd line treatment for tinea infection among topical application? *
  16. 1st line treatment 2nd line treatment 3rd line treatment
    Tinea corporis

    Tinea cruris

    Tinea pedis

  17. What is the 1st, 2nd and 3rd line treatment for tinea infection among systemic administration? *
  18. 1st line treatment 2nd line treatment 3rd line treatment
    Tinea corporis

    Tinea cruris

    Tinea pedis

  19. What is average duration of treatment in tinea infection? *
  20. Minimum duration of treatment for naïve cases. *
  21. Minimum duration of treatment for recalcitrant cases. *
  22. Topical antifungal should be continued for how long period after clinical resolution? *
  23. Which topical antifungal is your preferred molecule? *
  24. Which systemic antifungal is your preferred molecule? *
  25. What is the most common systemic and topical antifungal combination that you prefer in your patients? *
  26. Does super bioavailable Itraconazole show superior efficacy over conventional Itraconazole. If yes, how? *
  27. How many of your patients are compliant for the dermatophytosis treatment? *
  28. What are the main reasons behind non-compliance of patients to the dermatophytosis treatment? *
  29. Do you prescribe any adjuvant medications like antihistamine, moisturizer in addition to antifungals (topical or systemic) to your patients? *
  30. What is % of patients in which Amorolfine is prescribed? *
  31. When do you prefer a lotion formulation of a topical antifungal formulation? *
  32. What is % of patients in which anti-fungal soaps are prescribed? *
  33. What is % of patients in which anti-fungal powder are prescribed? *
  34. In which scenario anti-fungal powder are prescribed? *
  35. In what % of patients relapse is observed ? *
  36. What are the current challenges you are facing during treatment of Tinea.? *